BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 32657101)

  • 1. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report.
    Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C
    Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.
    Prince JS; Senac MO
    Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrolithiasis in a child with acute pyelonephritis. Ceftriaxone-induced nephrolithiasis and biliary pseudolithiasis.
    Tasic V; Sofijanova A; Avramoski V
    Pediatr Nephrol; 2005 Oct; 20(10):1510-1, 1512-3. PubMed ID: 16082553
    [No Abstract]   [Full Text] [Related]  

  • 4. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis.
    de Moor RA; Egberts AC; Schröder CH
    Eur J Pediatr; 1999 Dec; 158(12):975-7. PubMed ID: 10592073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone-induced pseudolithiasis in children treated for perforated appendicitis.
    Alemayehu H; Desai AA; Thomas P; Sharp SW; St Peter SD
    Pediatr Surg Int; 2014 Mar; 30(3):323-6. PubMed ID: 24464035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children.
    Ustyol L; Bulut MD; Agengin K; Bala KA; Yavuz A; Bora A; Demiroren K; Dogan M
    Hum Exp Toxicol; 2017 Jun; 36(6):547-553. PubMed ID: 27402682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases].
    Zhong XH; Chen H; Yao Y; Zhuo XW; Huang JP; Xiao HJ; Ai Y
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):216-9. PubMed ID: 20426960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis.
    Murata S; Aomatsu T; Yoden A; Tamai H
    Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children.
    Avci Z; Koktener A; Uras N; Catal F; Karadag A; Tekin O; Degirmencioglu H; Baskin E
    Arch Dis Child; 2004 Nov; 89(11):1069-72. PubMed ID: 15499067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children.
    Ozturk A; Kaya M; Zeyrek D; Ozturk E; Kat N; Ziylan SZ
    Acta Radiol; 2005 Feb; 46(1):112-6. PubMed ID: 15841750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.
    Mohkam M; Karimi A; Gharib A; Daneshmand H; Khatami A; Ghojevand N; Sharifian M
    Pediatr Nephrol; 2007 May; 22(5):690-4. PubMed ID: 17226043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough?
    Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R
    Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in Chinese children.
    Meng D; Cao Y; Fu J; Chen R; Lu L; Tu Y
    J Int Med Res; 2010; 38(6):2004-10. PubMed ID: 21227004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone-associated Biliary Pseudolithiasis with Elderly Type 1 Diabetes Mellitus: Two Case Reports.
    Kanazawa K; Suzuki S; Inaba T; Koga S; Kuwabara K
    Intern Med; 2023 Nov; 62(22):3367-3371. PubMed ID: 37032086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections.
    Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y
    Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone-associated Pseudolithiasis in the Gallbladder and Bile Duct of an Elderly Patient.
    Yamabe A; Irisawa A; Wakabayashi H; Tsunoda T; Tominaga K
    Intern Med; 2020 Nov; 59(21):2725-2728. PubMed ID: 32669492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical review and case report of ceftriaxone-associated gallbladder pseudolithiasis in adult].
    Jung HK; Lee DS
    Korean J Gastroenterol; 2014 Jun; 63(6):378-81. PubMed ID: 24953617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone-associated biliary pseudolithiasis in children.
    Biner B; Oner N; Celtik C; Bostancioğlu M; Tunçbilek N; Güzel A; Karasalihoğlu S
    J Clin Ultrasound; 2006 Jun; 34(5):217-22. PubMed ID: 16673364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of ceftriaxone in paediatrics: a systematic review.
    Zeng L; Wang C; Jiang M; Chen K; Zhong H; Chen Z; Huang L; Li H; Zhang L; Choonara I
    Arch Dis Child; 2020 Oct; 105(10):981-985. PubMed ID: 32144089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Pediatric ceftriaxone nephrolithiasis.
    Avci Z; Karadag A; Odemis E; Catal F
    J Urol; 2005 Sep; 174(3):1153. PubMed ID: 16094092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.